Sarepta Therapeutics (SRPT) Stock Price, Quote & News

Company Profile

Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat Duchenne muscular dystrophy (Duchenne) in patients with confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping; VYONDYS 53 for the treatment of Duchenne in patients with confirmed mutation of the dy...

Industry: Biotechnology

Sector: Healthcare

Phone: 617 274 4000

Website: www.sarepta.com

Address:

215 First Street, Suite 415, Cambridge, United States

1iquid Dec. 25 at 2:41 AM

💎 Liquid® Live Actionable Trade Asset: $SRPT Contracts: $SRPT January 15, 2027 $22 Calls Scale in: $7.57- $9.26 Scale out: $29.45-$50.49 Profit Potential : 64% ROI Blended Join 💎 Here: https://1iquid.com

0 · Reply

KarenXue Dec. 24 at 11:38 PM

$SRPT Buy companies solving real-world problems.

1 · Reply

Hoschton30548 Dec. 24 at 11:06 PM

$SRPT see you at $30

0 · Reply

BanditQ Dec. 24 at 10:30 PM

$BHVN $CAPR $SPRB , $SRPT Martin shkreli's bagholder army getting bigger and bigger. Fkn losers

2 · Reply

Plowmaster Dec. 24 at 10:21 PM

$SRPT Happy holidays. SRPT is finally starting to get recognized for what it is and there are so many reasons to look forward to 2026. We’ve been trending north and I honestly think a lot of the pressure earlier was just tax related. With newborn screening rolling out and the market finally seeing the long term picture the setup going into next year looks strong. This is still one of the most undervalued names in biotech in my opinion and 2026 should be the year people finally give it the credit it deserves.

2 · Reply

Sareptaking Dec. 24 at 9:41 PM

$SRPT News on Adam F. He’s been fired! https://x.com/newerraa/status/2003943653342077378?s=46&t=3Rpka8J_7wLE-OaZ-P25MA

1 · Reply

Astronaut_Trades Dec. 24 at 9:36 PM

$PYPL $VERI $NUKK $SRPT $JD merry Christmas to my astronaut community Sarepta to $90 pps

0 · Reply

Pharmer23 Dec. 24 at 8:30 PM

$SRPT merry Christmas everyone and have a happy new year . 2026 is the year of recovery.

0 · Reply

Find_the_Cure Dec. 24 at 8:04 PM

$SRPT how long for the afterhours shenanigans today

0 · Reply

Moemazon Dec. 24 at 7:48 PM

$SRPT

1 · Reply

Sarepta Therapeutics: Why The Newborn Screening Decision For DMD Matters More Than The Stock Move Suggests

Dec 11, 2025, 7:00 AM EST - 13 days ago

Sarepta Therapeutics Announces Refinancing of Approximately $291 Million of 1.25% Convertible Senior Notes due 2027

Nov 25, 2025, 12:07 PM EST - 4 weeks ago

Sarepta Secures FDA Nod For Elevidys Study To Reduce Liver Injury Risk

Nov 25, 2025, 8:57 AM EST - 4 weeks ago

Sarepta Announces Approval to Begin ENDEAVOR Cohort 8 to Evaluate Enhanced Immunosuppression Regimen as Part of ELEVIDYS Gene Therapy for Non-Ambulant Individuals with Duchenne

Nov 24, 2025, 7:30 AM EST - 4 weeks ago

Arrowhead Pharmaceuticals Earns $200 Million Milestone Payment from Sarepta Therapeutics

ARWR

Nov 24, 2025, 7:30 AM EST - 4 weeks ago

Sarepta Provides Progress Update for SRP-1003, its Investigational siRNA treatment for Myotonic Dystrophy Type 1

Nov 14, 2025, 5:48 PM EST - 5 weeks ago

Sarepta Shares Jump After FDA Approves Updated Elevidys Label

Nov 14, 2025, 2:54 PM EST - 5 weeks ago

Sarepta Announces FDA's Approval of Updated ELEVIDYS Prescribing Information

Nov 14, 2025, 2:08 PM EST - 5 weeks ago

US FDA adds strongest warning to Sarepta gene therapy after fatal liver injuries

Nov 4, 2025, 1:39 PM EST - 7 weeks ago

Sarepta Therapeutics: Why High Risk, Low Return Until Mid-To-Late 2026

Nov 4, 2025, 12:33 PM EST - 7 weeks ago

Sarepta Faces Investor Skepticism As Duchenne Data Falls Short Of Statistical Significance

Nov 4, 2025, 12:11 PM EST - 7 weeks ago

Sarepta Stock Dumps: Pharma Bro Martin Shkreli Still Likes It

Nov 4, 2025, 9:55 AM EST - 7 weeks ago

Sarepta Therapeutics shares plunge after disappointing trial data

Nov 4, 2025, 6:20 AM EST - 7 weeks ago

Sarepta Stock Tumbles 40%. Why the Biotech's Shares Are Sinking.

Nov 4, 2025, 5:36 AM EST - 7 weeks ago

Sarepta Therapeutics, Inc. (SRPT) Q3 2025 Earnings Call Transcript

Nov 4, 2025, 4:27 AM EST - 7 weeks ago

Sarepta slumps as gene therapy setback adds to drug pipeline woes

Nov 3, 2025, 6:26 PM EST - 7 weeks ago

Sarepta's stock plummets as disappointing trial data raise questions on DMD drug's success

Nov 3, 2025, 4:24 PM EST - 7 weeks ago

Sarepta's Duchenne gene therapy misses main goal in study

Nov 3, 2025, 4:05 PM EST - 7 weeks ago

Sarepta Therapeutics Announces Third Quarter 2025 Financial Results and Recent Corporate Developments, Including Completion of Its Confirmatory Study, ESSENCE

Oct 27, 2025, 4:05 PM EDT - 2 months ago

Sarepta Therapeutics to Announce Third Quarter 2025 Financial Results

Oct 23, 2025, 6:46 AM EDT - 2 months ago

Tradr Debuts Leveraged ETFs on BLSH, DASH, FLY, IREN, NEM, OPEN, QS, SRPT & WULF

BLSH DASH FLY IREN NEM OPEN QS

Oct 10, 2025, 11:49 AM EDT - 2 months ago

Sarepta Therapeutics: A Discounted Valuation Meets Breakthrough Pipeline

Oct 8, 2025, 11:19 AM EDT - 2 months ago

What's Going On Sarepta Stock On Wednesday?

Oct 3, 2025, 8:30 AM EDT - 2 months ago

Sarepta Therapeutics to Present New Data from its Neuromuscular Portfolio at 2025 World Muscle Society Congress

Sep 30, 2025, 6:00 PM EDT - 3 months ago

Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Sep 5, 2025, 9:00 AM EDT - 3 months ago

Sarepta Therapeutics Announces Recipients of Route 79, The Duchenne Scholarship Program, for the 2025-2026 Academic Year

Aug 28, 2025, 6:20 AM EDT - 4 months ago

mRNA Biotechs - Long-Term Value Risks Abound

ALNY BNTX DHR GRAL ILMN IONS MRNA

Aug 25, 2025, 3:11 AM EDT - 4 months ago

SRPT Shareholders Have the Right to Lead the Sarepta Therapeutics, Inc. Securities Lawsuit - Contact the DJS Law Group Before the Final Deadline - SRPT

Aug 23, 2025, 7:08 AM EDT - 4 months ago

SRPT CLASS REMINDER: Suffer Losses on Your Sarepta Therapeutics, Inc. Investment? Contact BFA Law before the August 25 Court Deadline (NASDAQ:SRPT)

Aug 22, 2025, 12:12 PM EDT - 4 months ago

Sarepta Therapeutics: A Strong Opportunity Amidst The Panic

Aug 22, 2025, 9:50 AM EDT - 4 months ago

SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Sarepta Therapeutics

Aug 21, 2025, 7:00 AM EDT - 4 months ago

Sarepta Therapeutics Announces Refinancing of Approximately $700 Million of 1.25% Convertible Senior Notes due 2027

Aug 20, 2025, 3:30 PM EDT - 4 months ago

SRPT Update: Hagens Berman Urges Sarepta Investors to Act Before August 25 Deadline

Aug 18, 2025, 12:01 PM EDT - 4 months ago

Sarepta Therapeutics (SRPT) August 25, 2025 Lead Plaintiff Deadline Approaching, SRPT Investors with Substantial Losses Encouraged to Contact Hagens Berman

Aug 14, 2025, 12:14 PM EDT - 4 months ago

SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Sarepta Therapeutics

Aug 13, 2025, 4:12 PM EDT - 4 months ago

Sarepta Therapeutics Announces Advancement of siRNA Collaboration and Sale of Arrowhead Equity Investment

Aug 13, 2025, 8:33 AM EDT - 4 months ago

SAREPTA STOCK: Lose Money on Your Sarepta Therapeutics, Inc. (NASDAQ:SRPT) Investment? Contact BFA Law before the August 25 Legal Deadline

Aug 11, 2025, 8:18 AM EDT - 4 months ago

SRPT COURT NOTICE: Sarepta Therapeutics Investors may have been Affected by Fraud -- Contact BFA Law before August 25 if You Suffered Losses (NASDAQ:SRPT)

Aug 11, 2025, 5:26 AM EDT - 4 months ago

These Stocks Are Moving the Most Today: Coinbase, MicroStrategy, Sarepta, Nvidia, AMD, and More

AMD COIN MSTR NVDA

Aug 6, 2025, 4:05 PM EDT - 5 months ago

Sarepta Therapeutics Announces Second Quarter 2025 Financial Results and Recent Corporate Developments

Jul 31, 2025, 8:48 AM EDT - 5 months ago

Sarepta Therapeutics to Announce Second Quarter 2025 Financial Results

Jul 31, 2025, 8:45 AM EDT - 5 months ago

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of August 25, 2025 in Sarepta Therapeutics, Inc. Lawsuit - SRPT

1iquid Dec. 25 at 2:41 AM

0 · Reply

KarenXue Dec. 24 at 11:38 PM

$SRPT Buy companies solving real-world problems.

1 · Reply

Hoschton30548 Dec. 24 at 11:06 PM

$SRPT see you at $30

0 · Reply

BanditQ Dec. 24 at 10:30 PM

$BHVN $CAPR $SPRB , $SRPT Martin shkreli's bagholder army getting bigger and bigger. Fkn losers

2 · Reply

Plowmaster Dec. 24 at 10:21 PM

2 · Reply

Sareptaking Dec. 24 at 9:41 PM

$SRPT News on Adam F. He’s been fired! https://x.com/newerraa/status/2003943653342077378?s=46&t=3Rpka8J_7wLE-OaZ-P25MA

1 · Reply

Astronaut_Trades Dec. 24 at 9:36 PM

$PYPL $VERI $NUKK $SRPT $JD merry Christmas to my astronaut community Sarepta to $90 pps

0 · Reply

Pharmer23 Dec. 24 at 8:30 PM

$SRPT merry Christmas everyone and have a happy new year . 2026 is the year of recovery.

0 · Reply

Find_the_Cure Dec. 24 at 8:04 PM

$SRPT how long for the afterhours shenanigans today

0 · Reply

Moemazon Dec. 24 at 7:48 PM

$SRPT

1 · Reply

Gladiator007 Dec. 24 at 7:27 PM

$SRPT Happy Holidays everyone

0 · Reply

OrphanAnniesBALLS Dec. 24 at 7:24 PM

$SRPT this still here? OMG...

0 · Reply

Gunnar_Bunker Dec. 24 at 6:18 PM

$SRPT it’s just a matter of time on this one going to be real fun when it begins ripping

3 · Reply

Stockwatcher9999 Dec. 24 at 6:16 PM

$SRPT Slow and steady this week! Enjoy the holidays

0 · Reply

free2dream Dec. 24 at 6:08 PM

$SRPT confidently adding on any pullback

1 · Reply

free2dream Dec. 24 at 4:35 PM

$SRPT https://youtu.be/IDar6he4g0w?si=68XlpTbbPV0x-wBG

0 · Reply

free2dream Dec. 24 at 4:01 PM

$SRPT don't ignore this, several days in the row now the calls significantly outpacing puts

1 · Reply

free2dream Dec. 24 at 3:55 PM

$SRPT and here we go, we actually might cross the algos resistance line today.

0 · Reply

free2dream Dec. 24 at 3:26 PM

$XBI $LABU $MYO $SRPT $MRNA

0 · Reply

free2dream Dec. 24 at 3:22 PM

$LITE scariest with these kind of parabolic moves is alway when they will pull the rug . I exited the trade here at $400, heck of a run. Looking for laggards and tax loss harvest victims like $SRPT and $MRNA

1 · Reply

gazza75799 Dec. 24 at 3:07 PM

$RGNX The next scheduled investor conference for REGENXBIO is the 44th Annual J.P. Morgan Healthcare Conference on Wednesday, January 14, 2026 at 10:30 a.m. PT (1:30 p.m. ET), at the Westin St. Francis in San Francisco. A live webcast link and a 30‑day replay will be available in the Investors section of REGENXBIO’s website. $XBI $SRPT

0 · Reply

free2dream Dec. 24 at 3:06 PM

$SRPT pinned by the algos in the range, but you can smell the tension here, once somebody pushes it over we are looking at some serious bounce . Keep an eye on it . $XBI $LABU

0 · Reply

Market Cap	2.22B
Revenue (ttm)	1.90B
Net Income (ttm)	235.24M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	12.37%
Debt to Equity Ratio	0.78

Volume	1,254,100
Avg Vol	4,592,750
Day's Range	N/A - N/A
Shares Out	104.79M
Stochastic %K	66%
Beta	0.54
Analysts	Sell
Price Target	$18.36